These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 21742784

  • 1. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
    Wang Z, Schley G, Türkoglu G, Burzlaff N, Amann KU, Willam C, Eckardt KU, Bernhardt WM.
    Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
    [Abstract] [Full Text] [Related]

  • 2. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM, Câmpean V, Kany S, Jürgensen JS, Weidemann A, Warnecke C, Arend M, Klaus S, Günzler V, Amann K, Willam C, Wiesener MS, Eckardt KU.
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
    Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Takahara S, Okuyama A.
    Transplantation; 2007 May 27; 83(10):1371-9. PubMed ID: 17519789
    [Abstract] [Full Text] [Related]

  • 4. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury.
    Jamadarkhana P, Chaudhary A, Chhipa L, Dubey A, Mohanan A, Gupta R, Deshpande S.
    Am J Nephrol; 2012 May 27; 36(3):208-18. PubMed ID: 22948183
    [Abstract] [Full Text] [Related]

  • 5. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
    Baek JH, Reiter CE, Manalo DJ, Buehler PW, Hider RC, Alayash AI.
    Biochim Biophys Acta; 2011 May 27; 1809(4-6):262-8. PubMed ID: 21558026
    [Abstract] [Full Text] [Related]

  • 6. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney.
    Rosenberger C, Rosen S, Shina A, Frei U, Eckardt KU, Flippin LA, Arend M, Klaus SJ, Heyman SN.
    Nephrol Dial Transplant; 2008 Nov 27; 23(11):3472-8. PubMed ID: 18515655
    [Abstract] [Full Text] [Related]

  • 7. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
    Heim C, Bernhardt W, Jalilova S, Wang Z, Motsch B, Ramsperger-Gleixner M, Burzlaff N, Weyand M, Eckardt KU, Ensminger SM.
    Interact Cardiovasc Thorac Surg; 2016 May 27; 22(5):561-70. PubMed ID: 26819270
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
    Souvenir R, Flores JJ, Ostrowski RP, Manaenko A, Duris K, Tang J.
    Transl Stroke Res; 2014 Feb 27; 5(1):118-27. PubMed ID: 24323731
    [Abstract] [Full Text] [Related]

  • 9. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X, Xu X, Fang Y, Zhang H, Liang M, Teng J, Ding X.
    Nephrology (Carlton); 2017 May 27; 22(5):366-373. PubMed ID: 27030384
    [Abstract] [Full Text] [Related]

  • 10. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.
    Yu X, Fang Y, Ding X, Liu H, Zhu J, Zou J, Xu X, Zhong Y.
    Nephrology (Carlton); 2012 Jan 27; 17(1):58-67. PubMed ID: 21777345
    [Abstract] [Full Text] [Related]

  • 11. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
    He K, Chen X, Han C, Xu L, Zhang J, Zhang M, Xia Q.
    Kidney Int; 2014 Feb 27; 85(2):276-88. PubMed ID: 24025643
    [Abstract] [Full Text] [Related]

  • 12. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
    Barnucz E, Veres G, Hegedűs P, Klein S, Zöller R, Radovits T, Korkmaz S, Horkay F, Merkely B, Karck M, Szabó G.
    J Pharmacol Exp Ther; 2013 Apr 27; 345(1):25-31. PubMed ID: 23388095
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
    Jones NM, Lee EM, Brown TG, Jarrott B, Beart PM.
    Neurosci Lett; 2006 Aug 14; 404(1-2):72-7. PubMed ID: 16828226
    [Abstract] [Full Text] [Related]

  • 14. Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.
    Schindler K, Bondeva T, Schindler C, Claus RA, Franke S, Wolf G.
    Nephrol Dial Transplant; 2016 Jul 14; 31(7):1100-13. PubMed ID: 26908768
    [Abstract] [Full Text] [Related]

  • 15. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C, Krischke G, Keller S, Walkinshaw G, Arend M, Rascher W, Gassmann M, Trollmann R.
    Brain Res; 2009 Jul 14; 1280():43-51. PubMed ID: 19450570
    [Abstract] [Full Text] [Related]

  • 16. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X, Fang Y, Liu H, Zhu J, Zou J, Xu X, Jiang S, Ding X.
    Nephrol Dial Transplant; 2012 Aug 14; 27(8):3110-9. PubMed ID: 22399494
    [Abstract] [Full Text] [Related]

  • 17. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H, Sridharan V, Wright G.
    Acta Physiol (Oxf); 2007 Jun 14; 190(2):163-9. PubMed ID: 17394573
    [Abstract] [Full Text] [Related]

  • 18. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS, Kiriakidis S, Paleolog EM, Davies AH.
    J Vasc Surg; 2012 May 14; 55(5):1427-39. PubMed ID: 22277691
    [Abstract] [Full Text] [Related]

  • 19. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S, Thirunavukkarasu M, Tipu Rishi M, Sanchez JA, Maulik N, Maulik G.
    Toxicol Mech Methods; 2012 Jun 14; 22(5):347-58. PubMed ID: 22424133
    [Abstract] [Full Text] [Related]

  • 20. Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
    Hong YA, Jung SY, Yang KJ, Im DS, Jeong KH, Park CW, Hwang HS.
    Int J Mol Sci; 2020 May 19; 21(10):. PubMed ID: 32438631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.